Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate

被引:17
|
作者
Le, V. N. P. [1 ]
Bierend, H. [2 ]
Robins, E. [3 ]
Steckel, H. [2 ]
Flament, M. P. [1 ]
机构
[1] Univ Lille Nord France, Coll Pharm, INSERM 1008, F-59006 Lille, France
[2] Univ Kiel, Inst Pharmaceut, D-24118 Kiel, Germany
[3] APTAR Pharma, F-27100 Le Vaudreuil, France
关键词
Dry powder inhalation; Lactose; Physicochemical properties; Adhesion; Aerodynamic behaviour; Inverse gas chromatography; INVERSE GAS-CHROMATOGRAPHY; SALBUTAMOL SULFATE; INHALATION FORMULATIONS; INTERACTIVE MIXTURES; SURFACE-ENERGY; IN-VITRO; PERFORMANCE; CARRIER; DISPERSION; FUNCTIONALITY;
D O I
10.1016/j.ijpharm.2011.10.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dry powder formulations are often composed of fine drug particles and coarser carrier particles, typically alpha-lactose monohydrate. However, the performance of a powder formulation may be highly dependent on the lactose quality and source. This study investigated the characteristics of lactose that influence the drug-to-carrier interaction and the performance of lactose-based dry powder inhaler formulations. The selected lactoses differed in the preparation processes and the content of fine lactose particles. Efficiency testing was done using fluticasone propionate and terbutaline sulphate as model drugs. Inverse gas chromatography was used to determine the surface heterogeneity distribution of different energy sites of the lactose and to understand the mechanism by which the fine carrier particles can improve the performance of dry powder inhalers. To assess the adhesion of respirable-sized drug to carrier particles, a simple method was developed based on aspiration and considering the whole blend as it is used in dry powder inhalers. When the percentage of fine lactose is high, a lower quantity of drug adheres to the lactose and/or the adhesion force is also lower. This was confirmed by the aerosolization assays done in the TSI (twin stage impinger). A correlation was observed between adhesion characteristics and inertial impaction. For both drugs, the fine particle fractions were highest in blends that present a greater proportion of lactose fine particles. A fairly good correlation between the fine particle fractions of both drugs and the peak max value and the AUC (area under curve) were found by inverse gas chromatography. With higher fine particle fraction values, which correspond to higher content of fines, the peak maxima determined by inverse gas chromatography were shifted to higher adsorption potentials, which supports the agglomeration hypothesis. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 50 条
  • [31] A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
    Mansfield, Lyndon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (04) : 264 - 276
  • [32] The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers
    Flament, MP
    Leterme, P
    Gayot, A
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) : 201 - 209
  • [33] The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers
    Kaialy, Waseem
    Martin, Gary P.
    Larhrib, Hassan
    Ticehurst, Martyn D.
    Kolosionek, Ewa
    Nokhodchi, Ali
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 89 : 29 - 39
  • [34] FLUTICASONE PROPIONATE AND FLUTICASONE/SALMETEROL MULTIDOSE DRY POWDER INHALERS IN PATIENTS PREVIOUSLY TREATED THROUGH ALTERNATIVE DEVICES
    Bernstein, D.
    Small, C.
    Yiu, G.
    Stoyanov, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S52 - S52
  • [35] Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers
    Soulele, K.
    Macheras, P.
    Silvestro, L.
    Savu, S. Rizea
    Karalis, V.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 80 : 33 - 42
  • [36] Effect of mouth wash on the removing fluticasone propionate delivered by dry powder inhaler in mouth
    Yokoyama, H
    Yamada, Y
    Yamamura, Y
    Nakamura, H
    Iga, T
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2001, 121 (03): : 233 - 237
  • [37] A generic fluticasone propionate and salmeterol dry powder inhaler: Evidence of usability, function, and robustness
    Tashkin, Donald P.
    Koltun, Arkady
    Wallace, Roisin
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (01) : 30 - 35
  • [38] Effect of USP induction ports and modified glass sampling apparatus on aerosolization performance of lactose carrier-based fluticasone propionate dry powder inhaler
    Mehta, Piyush P.
    Kadam, Shivajirao S.
    Pawar, Atmaram P.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 58
  • [39] Dry Powder Aerosols Generated by Standardized Entrainment Tubes From Drug Blends With Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate
    Xu, Zhen
    Mansour, Heidi M.
    Mulder, Tako
    McLean, Richard
    Langridge, John
    Hickey, Anthony J.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (08) : 3415 - 3429
  • [40] Novel spherical lactose produced by solid state crystallisation as a carrier for aerosolised salbutamol sulphate, beclomethasone dipropionate and fluticasone propionate
    Abadelah, Mohamad
    Thevarajah, Ursula
    Ahmed, Mahmud
    Seton, Linda
    Supuk, Enes
    Conway, Barbara R.
    Larhrib, Hassan
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 68